Yvette Anderson MPS[/caption]
Once a disease of the past, diphtheria is rapidly re-emerging across Australia. Here’s what pharmacists need to know.
AI is transforming pharmacy practice — but without the right safeguards, it can also put your registration at risk.
The RSV vaccination will soon be funded for older Australians on the National Immunisation Program (NIP) to ensure protection.
A new National Core Community Palliative Care Medicines List highlights the medicines community pharmacies should keep in stock.
Community pharmacies are often the first place people turn when something feels ‘off’. But as pharmacists know, many requests for over-the-counter medicines are more complex than they may initially seem.
A systematic review and meta-analysis found little evidence that cannabinoids improve outcomes for common conditions such as anxiety, post-traumatic stress disorder (PTSD) and other psychiatric disorders.
Opioid analgesic stewardship is now a national medicines safety priority, targeting preventable harm across acute settings and transitions to community care.
Adrenaline (epinephrine) nasal spray (neffy) was recently approved by the TGA and is now available for use in Australia.
Often complex, undiagnosed pelvic pain can leave patients in awful limbo. Pharmacists can help them understand what drives pain.
A recent systematic review has reignited debate about what happens when patients stop taking GLP-1 RAs and related incretin therapies.
